Melanin concentrating hormone receptor ligands (especially substituted benzoimidazole analogues), capable of modulating MCH receptor activity, are provided. Such ligands may be used to modulate MCH binding to MCH receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of metabolic, feeding and sexual disorders in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such ligands for detecting MCH receptors (e.g., receptor localization studies).
提供了黑素浓集激素受体
配体(尤其是取代
苯并咪唑类似物),能够调节
MCH受体活性。这样的
配体可以用于调节体内或体外
MCH结合到
MCH受体,并且在治疗人类、家畜伴侣动物和家畜动物的各种代谢、饮食和性功能障碍方面特别有用。提供了用于治疗这些疾病的药物组合物和方法,以及用于检测
MCH受体的方法(例如,受体定位研究)。